Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.
Chemiluminescence-Based Biosensors for Point-of-Care Multiplex Sensing as a Companion Diagnostics in Personalized Medicine Professor Aldo Roda, University of Bologna, speaking at Advances in Biodetection and Biosensors 2012.
Highly Sensitive and Rapid Magnetic Biosensors Wendy Dittmer, Philips Research, speaking at Advances in Biodetection ad Biosensors 2012.
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.
Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ Lymphoma Thomas Schirrmann PhD, Technische Universitaet Braunschweig, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA) Professor Roy Jefferis, College of Medical and Dental Sciences, University of Birmingham, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Biosimilars and the US-legislation: Analytical and Clinical Challenges Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Protein and Peptide Arrays for Studying Autoimmunity Professor Paul J. (P.J.) Utz, Stanford University, speaking at Microarray World Congress.